PeerView Internal Medicine CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Daily cadence·677 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 30 epsHosts
Not detected.
Recent guests
Recent episodes
Jill Stratford Waldron, APRN, GNP-BC - Winning Strategies for Managing Transthyretin Cardiac Amyloidosis: The Heart Failure Nurse’s Game Plan
Jul 20, 2026
1h 04m 47s
Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
Jul 13, 2026
53m 04s
Christie M. Ballantyne, MD, MNLA, FACP, FACC, Jessica M. Peña, MD, MPH, FACC, FNLA, FAHA - Combining Our Efforts for Patients With High-Risk ASCVD: Applying New Guidelines to Address the Challenge of Lipid Management
Jul 13, 2026
57m 21s
Paul E. Sax, MD / Eileen Scully, MD, PhD - Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care
Jul 13, 2026
1h 03m 22s
Maximilian Johannes Hochmair, MD / Zosia Piotrowska, MD, MHS - New Kids on the Block in Pretreated Metastatic EGFRm NSCLC: Emerging Strategies to Overcome Resistance
Jul 13, 2026
31m 24s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | Transthyretin Cardiac AmyloidosisHeart Failure+3 | Jill Stratford Waldron | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Transthyretin Cardiac AmyloidosisHeart Failure+3 | Alnylam Pharmaceuticals, Inc. | 1h 04m 47s | ||
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/13/26 | high-risk ASCVDlipid management+3 | Christie M. Ballantyne, MD, MNLA, FACP, FACCJessica M. Peña, MD, MPH, FACC, FNLA, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | ASCVDlipid management+3 | Merck & Co., Inc. | 57m 21s | ||
| 7/13/26 | HIV ManagementTherapeutic Advances+3 | Paul E. Sax, MDEileen Scully, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | HIVpatient care+3 | Merck & Co., Inc. | 1h 03m 22s | ||
| 7/13/26 | metastatic EGFRm NSCLCemerging strategies+3 | Maximilian Johannes Hochmair, MDZosia Piotrowska, MD, MHS | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | EGFRm NSCLCmetastatic cancer+3 | AstraZeneca | 31m 24s | ||
| 7/8/26 | clinical managementEGFRm NSCLC+3 | Natasha B. Leighl, MD, MMSc, FRCPC, FASCO, FCAHSNatasha B. Leighl | PVI, PeerView Institute for Medical EducationLUNGevity Foundation | — | EGFRm NSCLCpatient care+4 | AstraZeneca | 1h 28m 52s | ||
| 7/8/26 | immunotherapyNSCLC+3 | Ticiana Leal, MD | PVI, PeerView Institute for Medical EducationLUNGevity Foundation+3 | — | immunotherapyNSCLC+6 | AstraZeneca | 1h 23m 04s | ||
| 7/8/26 | Type 2 Diabetes ManagementEvidence-Based Practice+3 | Javier Morales, MD, FACP, FACE | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Type 2 DiabetesCME+4 | Lilly | 1h 03m 51s | ||
| 7/8/26 | Colorectal CancerImmunotherapy+3 | Scott Kopetz, MD, PhD, FACP | PVI, PeerView Institute for Medical EducationColorectal Cancer Alliance | — | CMECRC Treatment+3 | Bristol Myers Squibb | 1h 33m 32s | ||
| 7/8/26 | bladder cancerhealthcare innovations+3 | Matthew D. Galsky, MD | PVI, PeerView Institute for Medical EducationWorld Bladder Cancer Patient Coalition | Rahway, NJ, USA | bladder cancerCME+4 | Astellas | 1h 26m 52s | ||
| 5/29/26 | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Jaume Capdevila, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Neuroendocrine CarcinomaDLL3-Directed BiTE Therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 54m 53s | ||
| 5/29/26 | cognitive declinedementia risk+3 | Anna Chodos, MD, MPH | PVI, PeerView Institute for Medical EducationBrightFocus Foundation+3 | — | cognitive declinedementia+5 | Lilly | 46m 16s | ||
| 5/29/26 | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | ||
| 5/29/26 | Asparaginase exposurePediatric treatment+4 | Luke Maese, DORachel Rau, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Asparaginasepediatric oncology+4 | Jazz Pharmaceuticals | 48m 37s | ||
| 5/29/26 | Acute Lymphoblastic LeukemiaBispecific Options+3 | Ibrahim Aldoss, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Acute Lymphoblastic Leukemiabispecific therapy+4 | AstraZeneca | 37m 51s | ||
| 5/29/26 | InflammationFibrosis+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Inflammatory Bowel DiseaseTL1A Inhibition+4 | Merck & Co., Inc. | 1h 10m 58s | ||
| 5/25/26 | Alzheimer's DiseaseDetection+4 | Professor Frank Jessen, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseCME+5 | Lilly | 31m 48s | ||
| 5/25/26 | IgA NephropathyStandards of Care+3 | Gerald Appel, MDEllie Kelepouris, MD, FACP, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | IgA NephropathyCME+3 | Novartis Pharmaceuticals Corporation | 1h 02m 27s | ||
| 5/12/26 | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | retinal treatmentanti-VEGF+4 | Genentech | 35m 36s | ||
| 5/12/26 | Transthyretin Cardiac AmyloidosisInternal Medicine+3 | Julie L. Rosenthal, MD, FACCRonald Witteles, MD, FACC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Transthyretin Cardiac Amyloidosisinternal medicine+5 | Alnylam Pharmaceuticals, Inc. | 59m 02s | ||
| 5/7/26 | Restless Legs SyndromeTreatment Guidelines+3 | J. Andrew Berkowski, MD, FAASM | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Restless Legs Syndrometreatment gaps+3 | Noctrix Health, Inc. | 46m 37s | ||
| 5/7/26 | Parkinson's DiseasePsychosis+3 | — | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | April 29, 2027 | Parkinson's Diseasepsychosis+5 | ACADIA Pharmaceuticals Inc. | 56m 47s | ||
| 5/7/26 | Alzheimer's DiseaseAPOE Status+4 | Professor Christopher ChenProfessor Atsushi Iwata, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | APOEAlzheimer's Disease+4 | Lilly | 45m 04s | ||
| 5/7/26 | pharmacist principlesBTK targeting+4 | David Sabatino, PharmD, BCOPMarie E. Sirek, PharmD, BCACP, CPP | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | BTK inhibitorschronic lymphocytic leukemia+4 | AstraZeneca | 57m 33s | ||
| 5/7/26 | PCSK9 InhibitionLDL-C Targets+3 | Christie M. Ballantyne, MD, FACP, FACC | PVI, PeerView Institute for Medical EducationThe Mended Hearts, Inc. | Rahway, NJ, USA | PCSK9LDL-C+5 | Merck & Co., Inc. | 1h 22m 52s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.